Cutera, Inc. Reports Inducement Grants as permitted by the Nasdaq Listing Rules

Cutera, Inc. (Nasdaq: CUTR) ("Cutera" or the "Company"), a leading provider of aesthetic and dermatology solutions, today announced that Stephana Patton, who joined Cutera on November 13, 2023, as the Chief Legal Officer will receive a grant of inducement awards. The inducement awards consisted of stock options to purchase 30,000 of common stock, restricted stock units (RSUs) settleable in 25,000 shares of common stock, and performance stock units (PSUs) settleable in 55,000 shares of common stock. These awards will be approved by the Compensation Committee of Cutera's Board of Directors at its next regularly scheduled meeting.

The stock options will have an exercise price equal to the closing price of Cutera common stock on the grant date. A quantity of 25% shall vest on November 13, 2024, and 1/48 of the grant total shall vest each month thereafter, subject to Ms. Patton continuing as an employee.

A quantity of 25% of the RSUs shall vest on November 13, 2024, and 1/12 of the RSUs shall vest each quarter thereafter, subject to Ms. Patton continuing as an employee.

The vesting of a grant of 25,000 PSUs is based on the achievement of a $10.00 share price within four years of grant. The vesting of a grant of 30,000 PSUs is based on the achievement of a $20.00 share price within four years of the grant date.

Each inducement award is subject to the terms of the Cutera, Inc. 2023 Inducement Equity Incentive Plan and related forms of agreements and were granted as inducements material to these employees to enter into employment with Cutera in accordance with Nasdaq Listing Rule 5635(c)(4).

About Cutera, Inc.

Cutera is a leading provider of aesthetic and dermatology solutions for practitioners worldwide. Since 1998, Cutera has been developing innovative, easy-to-use products that harness the power of science and nature to enable medical practitioners to offer safe and effective treatments to their patients. For more information, call +1-415-657-5500 or 1-888-4CUTERA or visit www.cutera.com.